Back to REGN
PRINCIPAL FINANCIAL GROUP INC → REGN
PRINCIPAL FINANCIAL GROUP INC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$81.4M
Q3 2026
Peak value
$92.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $958K |
| Q3 2025 | $65.7M |
| Q4 2025 | $91.2M |
| Q4 2025 | $1.1M |
| Q1 2026 | $712K |
| Q1 2026 | $92.3M |
| Q2 2026 | $1.1M |
| Q2 2026 | $73.1M |
| Q2 2026 | $1.3M |
| Q3 2026 | $1.6M |
| Q3 2026 | $943K |
| Q3 2026 | $81.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $81.4M | 107.4K | — | — |
| Q3 2026 | $943K | 1.2K | — | — |
| Q3 2026 | $1.6M | 2.1K | — | — |
| Q2 2026 | $1.3M | 2.1K | — | — |
| Q2 2026 | $73.1M | 117.3K | — | — |
| Q2 2026 | $1.1M | 1.7K | — | — |
| Q1 2026 | $92.3M | 119.5K | — | — |
| Q1 2026 | $712K | 922 | — | — |
| Q4 2025 | $1.1M | 1.4K | — | — |
| Q4 2025 | $91.2M | 118.2K | — | — |
| Q3 2025 | $65.7M | 116.8K | — | — |
| Q3 2025 | $958K | 1.7K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B